InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells (Q2866735): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
Q2988597 (Deleted Item) | |||
| Property / beneficiary: Q2988597 (Deleted Item) / rank | |||
Normal rank | |||
Revision as of 19:17, 7 July 2021
Project Q2866735 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | InsideTumorCells: Cancer therapy with reduced systemic exposure and release of the drug into tumour cells |
Project Q2866735 in Portugal |
Statements
42,500.0 Euro
0 references
76.0 percent
0 references
18 June 2019
0 references
15 February 2022
0 references
UNIVERSIDADE DE COIMBRA
0 references
Q2988597 (Deleted Item)
0 references
40°12'40.28"N, 8°25'46.06"W
0 references
InsideTumorCells pretende proteger por patente os direitos de PI de um novo medicamento para o cancro que liberta o fármaco dentro das células tumorais, minimizando os efeitos secundários. (Portuguese)
0 references
InsideTumorCells intends to patently protect the IP rights of a new cancer medicine that releases the drug into tumour cells, minimising side effects. (English)
7 July 2021
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0145-FEDER-042773
0 references